Loading clinical trials...

Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome | Clinical Trials | Clareo Health

COMPLETED

Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome

Functional MRI Guided Accelerated Intermittent Theta Burst Stimulation for Chronic Post-Concussive Syndrome: A Feasibility and Efficacy Retrospective Chart Review

NCT07211919•Cognitive FX

View on ClinicalTrials.gov

Summary

This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain scan data were then compared before and after treatment.

Eligibility

Age

16 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Chronic or acute concussion symptoms

Exclusion Criteria

•MDD, GAD, bipolar depression, PTSD, schizophrenia, metal implants in skull, pacemaker, history of seizures, epilepsy

Locations (1)

Cognitive FX TMS Clinic

Provo, Utah, United States

Key Dates

Start Date

May 1, 2025

Primary Completion Date

June 30, 2025

Completion Date

July 31, 2025

Last Updated

October 10, 2025

Enrollment

ACTUAL participants

Conditions

Post Concussive Syndrome, ChronicPost Concussion SymptomsPost Concussive SyndromePost Concussion SyndromeAnxiety Disorder Not Otherwise Specified

RTL Concussion Communication

NCT06212726

Concussion, MildPost Concussion Symptoms+6 more

View study

UNKNOWNNA

Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial

NCT00237705

Post Concussive HeadachePost Concussive Syndrome

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions